首页> 美国卫生研究院文献>Clinical and Translational Gastroenterology >Prognostic Factors for Transplant-Free Survival and Validation of Prognostic Models in Chinese Patients with Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid

【2h】

Prognostic Factors for Transplant-Free Survival and Validation of Prognostic Models in Chinese Patients with Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid

机译：中国原发性胆源性胆管炎患者接受熊去氧胆酸的无移植存活预后因素及预后模型验证

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objectives:We aimed to validate the prognostic models for primary biliary cholangitis (PBC) in Chinese patients receiving ursodeoxycholic acid (UCDA), and to compare their performances in predicting the long-term survival.

机译：目的：我们旨在验证接受熊去氧胆酸（UCDA）的中国患者原发性胆源性胆管炎（PBC）的预后模型，并比较其在预测长期生存中的表现。

著录项

期刊名称 Clinical and Translational Gastroenterology
作者
Ka-Shing Cheung; Wai-Kay Seto; James Fung; Ching-Lung Lai; Man-Fung Yuen;
展开▼
作者单位

展开▼
年(卷),期 2017(8),6
年度 2017
页码 e100
总页数 10
原文格式 PDF
正文语种
中图分类肠道病毒与肝炎病毒;肝及胆疾病;肠疾病;
关键词
入库时间 2022-08-17 13:03:32

相似文献

外文文献
中文文献
专利

1. Prognostic Factors for Transplant-Free Survival and Validation of Prognostic Models in Chinese Patients with Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid [J] . Ka-ShingCheung, Wai-KaySeto, JamesFung, Clinical and Translational Gastroenterology . 2017,第6期

机译：中国原发性胆汁性胆管炎接受熊去氧胆酸患者无移植生存的预后因素及预后模型的验证
2. Evaluation of the United Kingdom‐primary biliary cholangitis and global primary biliary cholangitis group prognostic models for primary biliary cholangitis patients treated with ursodeoxycholic acid in the U.S. population [J] . Mohammad Alomari, Fahrettin Covut, Laith Al Momani, JGH OPEN . 2020,第2期

机译：基前胆囊炎与丙酮酸胆酸治疗原发性胆管炎患者的英国原发性胆管炎和全球原发性胆囊炎群预后模型
3. Time-dependent factors associated with diminished transplant-free survival in patients with primary biliary cholangitis and an optimal response to ursodeoxycholic acid after one year of treatment [J] . Lammers Willem J., Goet Jorn C., Mayo Marlyn J., Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第Suppla1期

机译：与原发性胆管炎患者患者的无移植存活率和对治疗一年后对熊酸胆酸的最佳反应相关的时间依赖性因素
4. Ursodeoxycholic Acid therapy Affects the Cytokine Network and Plays An Immunomodulatory Role in Patients With Primary Sclerosing Cholangitis and Primary Biliary Cirrhosis [C] . M. G. Neuman, P. Angulo, I. M. Malkiewicz, Falk Symposium . 2003

机译：核糖核酸酸治疗影响细胞因子网络，并对初级硬化胆管炎和原发性胆汁肝硬化患者发挥免疫调节作用
5. Predicting outcomes post liver transplantation in patients with primary biliary cirrhosis and primary sclerosing cholangitis. [D] . Zapatochny Rufo, Rebecca Jo. 2003

机译：预测原发性胆汁性肝硬化和原发性硬化性胆管炎患者肝移植后的结局。
6. Evaluation of the United Kingdom‐primary biliary cholangitis and global primary biliary cholangitis group prognostic models for primary biliary cholangitis patients treated with ursodeoxycholic acid in the U.S. population [O] . Mohammad Alomari, Fahrettin Covut, Laith Al Momani, 2020

机译：评估美国原发性胆管性胆管炎和全球原发性胆管性胆管炎组在美国人群中接受熊去氧胆酸治疗的原发性胆管性胆管炎患者的预后模型
7. Prognostic Factors for Transplant-Free Survival and Validation of Prognostic Models in Chinese Patients with Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid [O] . Cheung KS, Seto WKW, Fung JYY, 2017

机译：中国原发性胆汁性胆管炎患者接受熊去氧胆酸后移植物存活率及预后模型验证的预后因素

Prognostic Factors for Transplant-Free Survival and Validation of Prognostic Models in Chinese Patients with Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid

摘要

著录项

相似文献

相关主题

期刊订阅